Tekla Life Sciences Investors (NYSE:HQL)

19.88
Delayed Data
As of 4:00pm ET
 -0.15 / -0.75%
Today’s Change
18.51
Today|||52-Week Range
22.70
+0.66%
Year-to-Date
SECTOR
Miscellaneous
INDUSTRY
Investment Trusts/Mutual Funds
MARKET CAP
$477.8M

Company Description

Tekla Life Sciences Investors operates as a closed-end investment fund or Investment trust. The firm engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.

Contact Information

Tekla Life Sciences Investors
100 Federal Street
Boston Massachusetts 02110
P:(617) 772-8500
Investor Relations:

Employees

Shareholders

Other institutional15.12%
Mutual fund holders1.67%
Individual stakeholders0.65%

Top Executives

Dan OmsteadPresident, Chief Executive Officer & Trustee
Jason C. AkusSenior Vice President-Research
Timothy L. GasperoniSenior Vice President-Research
Laura F. WoodwardSecretary, Treasurer & Chief Compliance Officer